Start Date
July 31, 2015
Primary Completion Date
July 31, 2020
Rituximab
375 mg/m2 by vein weekly for the first 4 weeks (Days 1, 8, 15, 22) then the day prior to each subsequent dose of Urelumab for the 12-week course.
Urelumab
8 mg by vein given every 3 weeks for 4 doses, starting Day 2 of the 12-week course.
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
M.D. Anderson Cancer Center
OTHER